TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision
Zeyu Chen(Kingmed Diagnostics), E. John Wherry(Parker Institute for Cancer Immunotherapy), Golnaz Vahedi(University of Pennsylvania), Jennifer E. Wu(Parker Institute for Cancer Immunotherapy), Makoto Kurachi(University of Pennsylvania), Hongkai Ji(Johns Hopkins University), Omar Khan(University of Pennsylvania), Ramin S. Herati(University of Pennsylvania), Shelley L. Berger(University of Pennsylvania), Bertram Bengsch(University Medical Center Freiburg), Caiyue Xu(University of Pennsylvania), Ryan P. Staupe(University of Pennsylvania), Jean‐Christophe Beltra(University of Basel), Chi Wai Lau(Translational Therapeutics (United States)), Erietta Stelekati(Translational Therapeutics (United States)), Shin Foong Ngiow(Parker Institute for Cancer Immunotherapy), Laura A. Vella(Children's Hospital of Philadelphia), Zhangying Cai(University of Pennsylvania), Xiaolu Yang(University of Pennsylvania), Josephine R. Giles(Parker Institute for Cancer Immunotherapy), Zhicheng Ji(Johns Hopkins University), Amy E. Baxter(Translational Therapeutics (United States)), Alexander C. Huang(University of Pennsylvania), Sixiang Yu(University of Pennsylvania), Sasikanth Manne(Translational Therapeutics (United States)), John L. Johnson(University School), Laura M. McLane(University of Pennsylvania)
Cited by 703
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
T cell responses in patients with COVID-19
|Nature reviews. Immunology|2020|873
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|801